The role of state public health agencies in genetics and disease prevention: Results of a national survey

Margaret A. Piper, Joann M. Lindenmayer, Eugene J. Lengerich, Kenneth A. Pass, Wayne G. Brown, Wendy B. Crowder, Muin J. Khoury, Timothy G. Baker, Michele A. Lloyd-Puryear, Jacalyn L. Bryan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objectives. The onset and severity of the clinical expression of most diseases that are of public health importance are influenced by genetic predisposition. The ability to assess human genetic predisposition for many diseases is increasing rapidly. Therefore, state public health agencies should be incorporating new developments in genetics and disease prevention into their core functions of assessment, policy development, and assurance. The authors assessed the status of this process. Methods. The Council of State and Territorial Epidemiologists (CSTE) surveyed states about projects and concerns related to genetics and public health activities. Respondents were the Health Officer, the Maternal and Child Health/ Genetics Program Director, the Chronic Disease Program Director, and the Laboratory Director. Where applicable, responses were categorized into assessment, policy development, and assurance functions. Results. Thirty-eight (76%) state health departments responded. Ongoing genetics activities were assurance (82%), assessment (17%), and policy development (2%). In contrast, Health Officers responded that future genetics activities would be distributed differently: assurance, 41%; assessment, 36%; and policy development, 23%. Future assurance activities would be largely educational. Topics of interest and recently initiated activities in genetics were primarily assessment functions. Funding was the greatest concern, followed by lack of proven disease prevention measures and outcomes data. Conclusions. State health departments recognize a need to realign their activities to meet future developments in genetics. Lack of adequate resources, proven disease prevention measures, and outcomes data are potential barriers. Public health agencies need to develop a strategic plan to meet the opportunities associated with the development and implementation of genetic tests and procedures.

Original languageEnglish (US)
Pages (from-to)22-31
Number of pages10
JournalPublic Health Reports
Volume116
Issue number1
DOIs
StatePublished - Jan 1 2001

Fingerprint

Inborn Genetic Diseases
Public Health
Policy Making
Health
Genetic Predisposition to Disease
Outcome Assessment (Health Care)
Medical Genetics
Surveys and Questionnaires
Chronic Disease

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

Piper, Margaret A. ; Lindenmayer, Joann M. ; Lengerich, Eugene J. ; Pass, Kenneth A. ; Brown, Wayne G. ; Crowder, Wendy B. ; Khoury, Muin J. ; Baker, Timothy G. ; Lloyd-Puryear, Michele A. ; Bryan, Jacalyn L. / The role of state public health agencies in genetics and disease prevention : Results of a national survey. In: Public Health Reports. 2001 ; Vol. 116, No. 1. pp. 22-31.
@article{162c5c48808a4cb6b13a71de4f284d06,
title = "The role of state public health agencies in genetics and disease prevention: Results of a national survey",
abstract = "Objectives. The onset and severity of the clinical expression of most diseases that are of public health importance are influenced by genetic predisposition. The ability to assess human genetic predisposition for many diseases is increasing rapidly. Therefore, state public health agencies should be incorporating new developments in genetics and disease prevention into their core functions of assessment, policy development, and assurance. The authors assessed the status of this process. Methods. The Council of State and Territorial Epidemiologists (CSTE) surveyed states about projects and concerns related to genetics and public health activities. Respondents were the Health Officer, the Maternal and Child Health/ Genetics Program Director, the Chronic Disease Program Director, and the Laboratory Director. Where applicable, responses were categorized into assessment, policy development, and assurance functions. Results. Thirty-eight (76{\%}) state health departments responded. Ongoing genetics activities were assurance (82{\%}), assessment (17{\%}), and policy development (2{\%}). In contrast, Health Officers responded that future genetics activities would be distributed differently: assurance, 41{\%}; assessment, 36{\%}; and policy development, 23{\%}. Future assurance activities would be largely educational. Topics of interest and recently initiated activities in genetics were primarily assessment functions. Funding was the greatest concern, followed by lack of proven disease prevention measures and outcomes data. Conclusions. State health departments recognize a need to realign their activities to meet future developments in genetics. Lack of adequate resources, proven disease prevention measures, and outcomes data are potential barriers. Public health agencies need to develop a strategic plan to meet the opportunities associated with the development and implementation of genetic tests and procedures.",
author = "Piper, {Margaret A.} and Lindenmayer, {Joann M.} and Lengerich, {Eugene J.} and Pass, {Kenneth A.} and Brown, {Wayne G.} and Crowder, {Wendy B.} and Khoury, {Muin J.} and Baker, {Timothy G.} and Lloyd-Puryear, {Michele A.} and Bryan, {Jacalyn L.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0033-3549(04)50019-5",
language = "English (US)",
volume = "116",
pages = "22--31",
journal = "Public Health Reports",
issn = "0033-3549",
publisher = "Association of Schools of Public Health",
number = "1",

}

Piper, MA, Lindenmayer, JM, Lengerich, EJ, Pass, KA, Brown, WG, Crowder, WB, Khoury, MJ, Baker, TG, Lloyd-Puryear, MA & Bryan, JL 2001, 'The role of state public health agencies in genetics and disease prevention: Results of a national survey', Public Health Reports, vol. 116, no. 1, pp. 22-31. https://doi.org/10.1016/S0033-3549(04)50019-5

The role of state public health agencies in genetics and disease prevention : Results of a national survey. / Piper, Margaret A.; Lindenmayer, Joann M.; Lengerich, Eugene J.; Pass, Kenneth A.; Brown, Wayne G.; Crowder, Wendy B.; Khoury, Muin J.; Baker, Timothy G.; Lloyd-Puryear, Michele A.; Bryan, Jacalyn L.

In: Public Health Reports, Vol. 116, No. 1, 01.01.2001, p. 22-31.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The role of state public health agencies in genetics and disease prevention

T2 - Results of a national survey

AU - Piper, Margaret A.

AU - Lindenmayer, Joann M.

AU - Lengerich, Eugene J.

AU - Pass, Kenneth A.

AU - Brown, Wayne G.

AU - Crowder, Wendy B.

AU - Khoury, Muin J.

AU - Baker, Timothy G.

AU - Lloyd-Puryear, Michele A.

AU - Bryan, Jacalyn L.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Objectives. The onset and severity of the clinical expression of most diseases that are of public health importance are influenced by genetic predisposition. The ability to assess human genetic predisposition for many diseases is increasing rapidly. Therefore, state public health agencies should be incorporating new developments in genetics and disease prevention into their core functions of assessment, policy development, and assurance. The authors assessed the status of this process. Methods. The Council of State and Territorial Epidemiologists (CSTE) surveyed states about projects and concerns related to genetics and public health activities. Respondents were the Health Officer, the Maternal and Child Health/ Genetics Program Director, the Chronic Disease Program Director, and the Laboratory Director. Where applicable, responses were categorized into assessment, policy development, and assurance functions. Results. Thirty-eight (76%) state health departments responded. Ongoing genetics activities were assurance (82%), assessment (17%), and policy development (2%). In contrast, Health Officers responded that future genetics activities would be distributed differently: assurance, 41%; assessment, 36%; and policy development, 23%. Future assurance activities would be largely educational. Topics of interest and recently initiated activities in genetics were primarily assessment functions. Funding was the greatest concern, followed by lack of proven disease prevention measures and outcomes data. Conclusions. State health departments recognize a need to realign their activities to meet future developments in genetics. Lack of adequate resources, proven disease prevention measures, and outcomes data are potential barriers. Public health agencies need to develop a strategic plan to meet the opportunities associated with the development and implementation of genetic tests and procedures.

AB - Objectives. The onset and severity of the clinical expression of most diseases that are of public health importance are influenced by genetic predisposition. The ability to assess human genetic predisposition for many diseases is increasing rapidly. Therefore, state public health agencies should be incorporating new developments in genetics and disease prevention into their core functions of assessment, policy development, and assurance. The authors assessed the status of this process. Methods. The Council of State and Territorial Epidemiologists (CSTE) surveyed states about projects and concerns related to genetics and public health activities. Respondents were the Health Officer, the Maternal and Child Health/ Genetics Program Director, the Chronic Disease Program Director, and the Laboratory Director. Where applicable, responses were categorized into assessment, policy development, and assurance functions. Results. Thirty-eight (76%) state health departments responded. Ongoing genetics activities were assurance (82%), assessment (17%), and policy development (2%). In contrast, Health Officers responded that future genetics activities would be distributed differently: assurance, 41%; assessment, 36%; and policy development, 23%. Future assurance activities would be largely educational. Topics of interest and recently initiated activities in genetics were primarily assessment functions. Funding was the greatest concern, followed by lack of proven disease prevention measures and outcomes data. Conclusions. State health departments recognize a need to realign their activities to meet future developments in genetics. Lack of adequate resources, proven disease prevention measures, and outcomes data are potential barriers. Public health agencies need to develop a strategic plan to meet the opportunities associated with the development and implementation of genetic tests and procedures.

UR - http://www.scopus.com/inward/record.url?scp=0034852630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034852630&partnerID=8YFLogxK

U2 - 10.1016/S0033-3549(04)50019-5

DO - 10.1016/S0033-3549(04)50019-5

M3 - Article

C2 - 11571405

AN - SCOPUS:0034852630

VL - 116

SP - 22

EP - 31

JO - Public Health Reports

JF - Public Health Reports

SN - 0033-3549

IS - 1

ER -